1Mehta KA, Kislalioglu MS, Phuapradit W, et al. Release performance of a poorly soluble drug from a novel, Eudragit(R)based multi-unit erosion matrix [ J ]. Int J Pharm,2001, 213(1/2):7- 12.
2Pillay V, Fassihi R. In vitro release modulation from crosslinked pellets for site-specific drug delivery to the gastrointestinal tract. Ⅰ . Comparison of pH-responsive dmg release and associated kinetics[J]. J Control Release, 1999,59(2) :229 - 242.
3Santos H, Veiga F, Pina M, et al. Physical properties of chitosan pellets produced by extrusion-spheronisation: influence of formulation variables[J]. Int J Pharm, 2002, 246(1/2): 153 - 169.
4Alvarez L, Concheiro A, Gomez-Amoza JL, et al. Powdered cellulose as excipient for extrusion-spheronization pellets of a cohesive hydrophobic drug[J]. Eur J Pharm Biopharm, 20O3, 55(3) :291 - 295.
5Tho I, Snade SA, Kleinebudde P. Disintegrating pellets from a water-insoluble pectin derivative produced by extruion/spheronisation[J]. Eur J Pharm Biopharm, 2003,56(3) :371 - 380.
6Vergote GJ, Vervaet C, Van Driessche I, et al. An oral controlled release matrix pellet formulation containing nanocrystalline ketoprofen [ J]. Int J Pharm, 2001, 219(1/2): 81 - 87.
7Satoshi U, Hisani Y, Masateru K, et al. Development of a novel drug release system, time-controlled explosion system (TES). Ⅱ .Design of multiparticulate TES and in vitro drug release properties [J]. Chem Pharm Bull, 1994, 42 (2):359- 363.
8Ho HO, ChenCN, SheuMT. InfiuenceofpluronicF-68on dissolution and bioavailability characteristics of multiple-layer pellets of nifedipine for controlled release delivery[ J ]. J Control Release, 2000, 68(3):433-440.
9Lecomte F, Siepmann J, Walther M, et al. Blends of enteric and GIT-insoluble polymers used for film coating:physicochemical characterization and drug release patterns[J]. J Control Release, 2003, 89(3):457-471.
10Zheng W, McGinity JW. Influence of Eudragit(R)NE 30 D blended with Eudragit(R)L 30 D-55 on the release of phenylpropanolamine hydrochloride from coated pellets [ J]. Drug Dev Ind Pharm, 2003, 29(3):357-366.
